Jennifer L. Payne, MD

After FDA’s new warning, experts stress controlled data show acetaminophen in pregnancy isn’t tied to autism or ADHD; confounding fuels scares.

New analysis finds postpartum depression and postpartum psychosis have distinct underlying biological mechanisms.

A reproductive psychiatrist discusses the implications of recent FDA announcements on medication use during pregnancy, emphasizing the importance of mental health for mothers and babies.

"There is an urgency for competent, thoughtful mental health care for women—not only because the differences have been ignored in the past, but because women’s mental health so often affects health and mental health outcomes for their children."

Loss and suffering can be hard for both patient and provider. Here’s what we know, what we need to learn, and how to protect yourself as a clinician.

Mental illnesses are too often shrouded in secrecy and shame. What would happen if we spoke out about the cases we knew best—the ones in our own families?

Could the emerging field of epigenetics hold the key to catching postpartum depression before it happens?

Dr Payne previews her talk at the upcoming Annual Psychiatric Times® World CME Conference™, reminding us why it is important to take care of mothers postpartum.

Although they may have been the result of good intentions, these mistakes could adversely impact mother and baby.

This article describes common misconceptions about treatment of psychiatric illness during pregnancy and advocates for a logical and thoughtful approach to designing a treatment plan.

This article summarizes the risks of untreated psychiatric illness during pregnancy as well as the risks and benefits of antidepressant use.